fda removes tirzepatide from shortage list As of February 21, 2025, the updated its drug list, marking the semaglutide injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Mounjaro will remain off shortage

What do these terms mean

Does Either Accept Insurance

COVERAGE OUTLOOK What's Changing in 2026 2026: Diverging Trends The insurance landscape for Zepbound is splitting: Medicare/Medicaid expanding via new CMS pilot programs while many commercial plans are pulling back

If, for any reason, there are challenges with insurance coverage, there are other alternative payment options and assistance programs that you can explore to make Semaglutide GLP-1 injections more affordable

beehiiv is where they built it

They share a common therapeutic value: improved glycaemic control, weight reduction, and protection against cardiovascular and renal outcomes